Literature DB >> 17288947

[What is late gadolinium enhancement in hypertrophic cardiomyopathy?].

James C Moon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17288947

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN： 0300-8932            Impact factor:   4.753


× No keyword cloud information.
  6 in total

Review 1.  The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.

Authors:  Radwa A Noureldin; Songtao Liu; Marcelo S Nacif; Daniel P Judge; Marc K Halushka; Theodore P Abraham; Carolyn Ho; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-20       Impact factor: 5.364

2.  In vivo T2* weighted MRI visualizes cardiac lesions in murine models of acute and chronic viral myocarditis.

Authors:  Xavier Helluy; Martina Sauter; Yu-Xiang Ye; Gunthard Lykowsky; Jakob Kreutner; Ali Yilmaz; Roland Jahns; Valerie Boivin; Reinhard Kandolf; Peter M Jakob; Karl-Heinz Hiller; Karin Klingel
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

3.  Diagnostic performance of late gadolinium enhancement in the assessment of acute cellular rejection after heart transplantation.

Authors:  Evrim Şimşek; Sanem Nalbantgil; Naim Ceylan; Mehdi Zoghi; Hatice Soner Kemal; Çağatay Engin; Tahir Yağdı; Mustafa Özbaran
Journal:  Anatol J Cardiol       Date:  2015-06-18       Impact factor: 1.596

Review 4.  Native T1 reference values for nonischemic cardiomyopathies and populations with increased cardiovascular risk: A systematic review and meta-analysis.

Authors:  Maaike van den Boomen; Riemer H J A Slart; Enzo V Hulleman; Rudi A J O Dierckx; Birgitta K Velthuis; Pim van der Harst; David E Sosnovik; Ronald J H Borra; Niek H J Prakken
Journal:  J Magn Reson Imaging       Date:  2017-11-13       Impact factor: 4.813

5.  Assessment of stunned and viable myocardium using manganese-enhanced MRI.

Authors:  Nick B Spath; Trisha Singh; Giorgos Papanastasiou; Andrew Baker; Rob J Janiczek; Gerry P McCann; Marc R Dweck; Lucy Kershaw; David E Newby; Scott Semple
Journal:  Open Heart       Date:  2021-06

6.  Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.

Authors:  Grigorios Chatzantonis; Michael Bietenbeck; Anca Florian; Claudia Meier; Philipp Stalling; Dennis Korthals; Holger Reinecke; Ali Yilmaz
Journal:  Clin Res Cardiol       Date:  2020-05-05       Impact factor: 5.460
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.